Fertility Focus Release: Ovusense Fertility Monitor An Accurate App For Tracking Ovulation Awarded "Best For Fertility"

WARWICK, England, December 9, 2016 /PRNewswire/ --

New OvuSense fertility monitor App and Sensor promises hope for couples who are trying for a baby. OvuSense is a class 2 medical device that includes a Fertility App and personal Sensor. OvuSense is the only monitor that predicts and confirms ovulation, in real time, with 99% clinically proven accuracy. The Times named OvuSense, "best for fertility" in their article rounding up the best Apps for healthcare. [1]

Rob Milnes, CEO: "We set out to make OvuSense completely different - by going back to the key principles of the science and working with leading clinicians in development and clinical trials, we were able to discover a way of using temperature to predict ovultion in real time. Being named 'Best for Fertility' by The Times recognizes the hard work we've all put into making OvuSense the best fertility monitor money can buy." [2]

Kate Davies, fertility nurse specialist: "The key to OvuSense is that it monitors 'core temperature', providing a direct indication of the Progesterone released during ovulation. That's why I recommend OvuSense to all my patients."

Kirsty became pregnant with her first baby: "OvuSense helped to make me more aware of my natural ovulation signs in order to try and conceive. It happened! I used OvuSense for two months and now I'm pregnant after 8 long years of trying!"

Notes:

OvuSense was created by UK start-up eHealth company, Fertility Focus Ltd, based in Warwickshire.

http://www.ovusense.com

• Real time 24-hour advance ovulation prediction: OvuSense provides a day's advance notice of when you are going to ovulate in real time along with your 4-day ovulation window - proven in the clinical analysis to be correct 96% of the time.

• 8-day fertile window: OvuSense provides a full 8-day fertile window

• Fully certified: OvuSense is a fully regulated medical device and complies with all necessary certifications for the countries in which it is available - CE mark in Europe, FDA 510(k) in the USA, CMDCAS in Canada,TGA in Australia.

1: http://www.thetimes.co.uk/article/good-health-theres-an-app-for-it-wz3gt7q3p?shareToken=8164848b73192632b078eb7124d18d08 - The Times

2: http://www.ovusense.com/uk/clinical-information - clinical References

Media queries call: +44-(0)1926-400054 / Laura.Underwood@fertility-focus.com

Back to news